Browsing by Author "Caruntu, Florin A."
Now showing items 1-5 of 5
-
96 weeks of pegylated-Interferon- alpha-2? plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 study
Wedemeyer, Heiner; Yurdaydin, Cihan; Ernst, Stefanie; Caruntu, Florin A.; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S. (Wiley-Blackwell, 2013)[Abstract Not Available] -
Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis delta
Wranke, Anika; Yurdaydin, Cihan; Heidrich, Benjamin; Ernst, Stefanie; Koch, Armin; Serrano, Beatriz Calle; Caruntu, Florin A. (Wiley-Blackwell, 2013)[Abstract Not Available] -
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
Anastasiou, Olympia E.; Caruntu, Florin A.; Curescu, Manuela G.; Yalçın, Kendal; Akarca, Ulus S.; Gürel, Selim; Çelen, Mustafa Kemal (John Wiley and Sons Inc, 2024)Background & Aims: Until recently, pegylated interferon-alfa-2a (PEG-IFNa) therapy was the only treatment option for patients infected with hepatitis D virus (HDV). Treatment with PEG-IFNa with or without tenofovir disoproxil ... -
A novel non-invasive fibrosis score based on cytokines and clinical parameters for the use in chronic hepatitis delta
Heidrich, Benjamin; Wranke, Anika; Yurdaydin, Cihan; Stift, Judith; Caruntu, Florin A.; Curescu, Manuela G.; Yalcin, Kendal (Wiley-Blackwell, 2013)[Abstract Not Available] -
Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study
Yurdaydin, Cihan; Wedemeyer, Heiner; Caruntu, Florin A.; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S.; Gurel, Selim (Wiley-Blackwell, 2012)[Abstract Not Available]
